US 12,419,926 B2
Composition for preventing or treating cancer comprising Angelica gigas, Aconitum carmichaeli debeaux, and Zingiber officinale roscoe mixed extract as active ingredient
Seong-Gyu Ko, Seoul (KR)
Assigned to UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY, Gyeonggi-do (KR)
Appl. No. 17/639,040
Filed by UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY, Gyeonggi-do (KR)
PCT Filed Aug. 28, 2020, PCT No. PCT/KR2020/011530
§ 371(c)(1), (2) Date Feb. 28, 2022,
PCT Pub. No. WO2021/040449, PCT Pub. Date Mar. 4, 2021.
Claims priority of application No. 10-2019-0106051 (KR), filed on Aug. 28, 2019.
Prior Publication US 2022/0323526 A1, Oct. 13, 2022
Int. Cl. A61K 36/00 (2006.01); A61K 36/232 (2006.01); A61K 36/714 (2006.01); A61K 36/9068 (2006.01); A61P 11/00 (2006.01); A61P 35/00 (2006.01)
CPC A61K 36/232 (2013.01) [A61K 36/714 (2013.01); A61K 36/9068 (2013.01); A61P 11/00 (2018.01); A61P 35/00 (2018.01); A61K 2236/331 (2013.01); A61K 2236/333 (2013.01)] 4 Claims
 
1. A method for treating cancer, the method comprising administering a pharmaceutical composition comprising a mixed extract of Angelica gigas, Aconitum carmichaeli Debeaux, and Zingiber officinale Roscoe as an active ingredient, wherein the extract is an ethanol extract, and
wherein a mixing ratio of the extract of Angelica gigas, Aconitum carmichaeli Debeaux, and Zingiber officinale Roscoe is 1.5 to 2.5:0.5 to 1.5:0.5 to 1.5.